About electroCore, Inc. 
electroCore, Inc.
Pharmaceuticals & Biotechnology
ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.
Company Coordinates 
Company Details
150 Allen Rd Ste 201 , Basking Ridge NJ : 07920-2977
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (4.7%)
Foreign Institutions
Held by 9 Foreign Institutions (1.01%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Michael Atieh
Independent Chairman of the Board
Mr. Daniel Goldberger
Chief Executive Officer, Director
Mr. Joseph Errico
Director
Mr. Peter Cuneo
Independent Director
Dr. Thomas Errico
Independent Director
Mr. John Gandolfo
Independent Director
Mr. Trevor Moody
Independent Director
Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
Pharmaceuticals & Biotechnology
USD 37 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-6.28
-1,190.57%
33.52






